Roche's fat-burning drug shows promise for diabetes

12/14/2011 | Bloomberg

Roche Holding's experimental fat-burning drug helped lower blood glucose levels for 30 days and induce a 10% weight reduction in mice with diabetes, a study in Science Translational Medicine revealed. The drug also helped activate calorie-burning brown fats, increase energy spending and decrease liver fat, researchers said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD